Article, Clinical Endpoint Experts / 09.08.2023
4 Reasons to Partner with a Respiratory Clinical Endpoint Expert
Discover 4 reasons to partner with a clinical endpoint expert for your next respiratory trial....
Discover 4 reasons to partner with a clinical endpoint expert for your next respiratory trial....
Given that the relative survival rate of patients diagnosed with metastatic lung cancer is low, and that traditional chemotherapy and surgery are of limited efficacy, ADCs represent a potentially important treatment option....